Zacks Research reduced their Q2 2025 earnings estimates for shares of American Financial Group in a research report issued to ...

JLL's Q4 results reflect accelerated transactional activity and continued strength in resilient revenues despite volatility.

BioMarin Pharmaceutical BMRN reported fourth-quarter adjusted earnings per share of 92 cents, which beat the Zacks Consensus ...

Ionis Pharmaceuticals IONS incurred a loss of 66 cents per share for fourth-quarter 2024, which was narrower than the Zacks ...

Gildan Activewear's Q4 results reflect higher sales and earnings. The adjusted gross margin increases y/y due to lower raw ...

Equities research analysts at Zacks Research cut their Q2 2025 earnings estimates for WaFd in a note issued to investors on ...

The Zacks Consensus Estimate for the to-be-reported quarter’s earnings and revenues is pegged at 76 cents per share and $27.61 billion, respectively. See the Zacks Earnings Calendar to stay ...

Barring one-time items, adjusted earnings per share were $1.79, beating the Zacks Consensus Estimate of $1.61. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. Revenues were ...